Epidermal growth factor receptor mutations in 510 finnish non-small-cell lung cancer patients

Journal of Thoracic Oncology

Volumn 9, Issue 6, 2014, Pages 886-891

  Mäki Nevala, Satu ^a   Rönty, Mikko ^b   Morel, Mike ^c   Gomez, Maria ^c   Dawson, Zoe ^c   Sarhadi, Virinder Kaur ^a   Telaranta Keerie, Aino ^c   Knuuttila, Aija ^b   Knuutila, Sakari ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Lab21 Ltd   (United Kingdom)

Author keywords

EGFR; Frequency; Lung adenocarcinoma; Mutations; Non small cell lung cancer

Indexed keywords

ERLOTINIB; GEFITINIB; ASBESTOS; EPIDERMAL GROWTH FACTOR RECEPTOR;

AGED; ARTICLE; CANCER PATIENT; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; EXON; FEMALE; GENE; GENE DELETION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OVERALL SURVIVAL; PLEURA EFFUSION; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; FINLAND; GENETICS; LUNG NEOPLASMS; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE;

ADENOCARCINOMA; AGED; ASBESTOS; CARCINOMA, NON-SMALL-CELL LUNG; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; FINLAND; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEX FACTORS; SMOKING; SURVIVAL RATE;

EID: 84901472335     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000132     Document Type: Article

References (15)

1. Mitsudomi T, Yatabe Y. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J 2010;277:301-308.
2. Travis WD, Brambilla E, Noguchi M, et al.; American Thoracic Society. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc 2011;8:381-385.
3. Tuononen K, Mäki-Nevala S, Sarhadi VK, et al. Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin- embedded tumor material of non-small cell lung carcinoma- superiority of NGS. Genes Chromosomes Cancer 2013;52:503-511.
4. Helland Å, Skaug HM, Kleinberg L, et al. EGFR gene alterations in a Norwegian cohort of lung cancer patients selected for surgery. J Thorac Oncol 2011;6:947-950.
5. Smits AJ, Kummer JA, Hinrichs JW, et al. EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma. Cell Oncol (Dordr) 2012;35:189-196.
6. Boch C, Kollmeier J, Roth A, et al. The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study. BMJ Open 2013;3:e002560.
7. Russell PA, Barnett SA, Walkiewicz M, et al. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients. J Thorac Oncol 2013;8:461-468.
8. Li H, Pan Y, Li Y, et al. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose. Lung Cancer 2013;79:8-13.
9. Kobayashi S, Canepa HM, Bailey AS, et al. Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors. J Thorac Oncol 2013;8:45-51.
10. Hata A, Yoshioka H, Fujita S, et al. Complex mutations in the epidermal growth factor receptor gene in non-small cell lung cancer. J Thorac Oncol 2010;5:1524-1528.
11. Johnson ML, Sima CS, Chaft J, et al. Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas. Cancer 2013;119:356-362.
12. Kim YT, Seong YW, Jung YJ, et al. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer. J Thorac Oncol 2013;8:171-178.
13. Rosell R, Moran T, Queralt C, et al.; Spanish Lung Cancer Group. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009;361:958-967.
14. Bae NC, Chae MH, Lee MH, et al. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Cancer Genet Cytogenet 2007;173:107-113. (Pubitemid 46281348)
15. Li Y, Li Y, Yang T, et al. Clinical significance of EML4-ALK fusion gene and association with EGFR and KRAS gene mutations in 208 Chinese patients with non-small cell lung cancer. PLoS One 2013;8:e52093.